AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33

Authors: Messele, T De Wit, TFR Brouwer, M Aklilu, M Birru, T Fontanet, AL Schuitemaker, H Hamann, D
Citation: T. Messele et al., No difference in in vitro susceptibility to HIV type 1 between high-risk HIV-negative ethiopian commercial sex workers and low-risk control subjects, AIDS RES H, 17(5), 2001, pp. 433-441

Authors: Van Praag, RME Prins, JM Roos, MTL Schellekens, PTA Ten Berge, IJM Yong, SL Schuitemaker, H Eerenberg, AJM Jurriaans, S De Wolf, F Fox, CH Goudsmit, J Miedema, F Lange, JMA
Citation: Rme. Van Praag et al., OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+T cell depletion, J CLIN IMM, 21(3), 2001, pp. 218-226

Authors: Vyakarnam, A Eyeson, J Teo, I Zuckerman, M Babaahmady, K Schuitemaker, H Shaunak, S Rostron, T Rowland-Jones, S Simmons, G Clapham, P
Citation: A. Vyakarnam et al., Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells, AIDS, 15(13), 2001, pp. 1613-1626

Authors: Reijers, MHE Weverling, GJ Jurriaans, S Roos, MTL Wit, FWNM Weigel, HM Ten Kate, RW Mulder, JW Richter, C Ter Hofstede, HJM Sprenger, H Hoetelmans, RMW Schuitemaker, H Lange, JMA
Citation: Mhe. Reijers et al., The ADAM study continued: maintenance therapy after 50 weeks of induction therapy, AIDS, 15(1), 2001, pp. 129-131

Authors: Beaumont, T van Nuenen, A Broersen, S Blattner, WA Lukashov, VV Schuitemaker, H
Citation: T. Beaumont et al., Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course, J VIROLOGY, 75(5), 2001, pp. 2246-2252

Authors: Kwa, D Vingerhoed, J Boeser-Nunnink, B Broersen, S Schuitemaker, H
Citation: D. Kwa et al., Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4(+)T-cell subsets are determined only by coreceptor expression, J VIROLOGY, 75(21), 2001, pp. 10455-10459

Authors: Kreisberg, JF Kwa, D Schramm, B Trautner, V Connor, R Schuitemaker, H Mullins, JI van't Wout, AB Goldsmith, MA
Citation: Jf. Kreisberg et al., Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status, J VIROLOGY, 75(18), 2001, pp. 8842-8847

Authors: Koning, FA Schols, D Schuitemaker, H
Citation: Fa. Koning et al., No selection for CCR5 coreceptor usage during parenteral transmission of macrophagetropic syncytium-inducing human immunodeficiency virus type 1, J VIROLOGY, 75(18), 2001, pp. 8848-8853

Authors: Hazenberg, MD Hamann, D Schuitemaker, H Miedema, F
Citation: Md. Hazenberg et al., T cell depletion in HIV-I infection: how CD4(+) T cells go out of stock, NAT IMMUNOL, 1(4), 2000, pp. 285-289

Authors: Maas, JJJ Gange, SJ Schuitemaker, H Coutinho, RA van Leeuwen, R Margolick, JB
Citation: Jjj. Maas et al., Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study, AIDS, 14(9), 2000, pp. 1155-1161

Authors: Kostense, S Krop, E Blaak, H Schuitemaker, H Miedema, F
Citation: S. Kostense et al., Normalization of the CD4 T cell receptor repertoire after evolution of syncytium-inducing HIV-1 variants, AIDS, 14(3), 2000, pp. 330-331

Authors: Putter, H Prins, JM Jurriaans, S Roos, M Ferguson, NM van Praag, R van der Hoek, L Schuitemaker, H Anderson, RM Goudsmit, J Lange, JMA de Wolf, F
Citation: H. Putter et al., Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection, AIDS, 14(18), 2000, pp. 2831-2839

Authors: Reijers, MHE Weigel, HM Hart, AAM Ten Kate, RW Mulder, JW Reiss, P Schuitemaker, H Hoetelmans, RMW Weverling, GJ Lange, JMA
Citation: Mhe. Reijers et al., Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study, AIDS, 14(1), 2000, pp. 59-68

Authors: Blaak, H Ran, LJ Rientsma, R Schuitemaker, H
Citation: H. Blaak et al., Susceptibility of in vitro stimulated PBMC to infection with NSIHIV-1 is associated with levels of CCR5 expression and beta-chemokine production, VIROLOGY, 267(2), 2000, pp. 237-246

Authors: Blaak, H van't Wout, AB Brouwer, M Hooibrink, B Hovenkamp, E Schuitemaker, H
Citation: H. Blaak et al., In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline, P NAS US, 97(3), 2000, pp. 1269-1274

Authors: Scoggins, RM Taylor, JR Patrie, J van't Wout, AB Schuitemaker, H Camerini, D
Citation: Rm. Scoggins et al., Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice, J VIROLOGY, 74(7), 2000, pp. 3205-3216

Authors: Kootstra, NA Zwart, BM Schuitemaker, H
Citation: Na. Kootstra et al., Diminished human immunodeficiency virus type 1 reverse transcription and nuclear transport in primary macrophages arrested in early G(1) phase of thecell cycle, J VIROLOGY, 74(4), 2000, pp. 1712-1717

Authors: Beaumont, T Broersen, S van Nuenen, AD Huisman, HG Husman, AMD Heeney, JL Schuitemaker, H
Citation: T. Beaumont et al., Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees, J VIROLOGY, 74(17), 2000, pp. 7699-7707

Authors: van Rij, RP Blaak, H Visser, JA Brouwer, M Rientsma, R Broersen, S Husman, AMD Schuitemaker, H
Citation: Rp. Van Rij et al., Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1, J CLIN INV, 106(8), 2000, pp. 1039-1052

Authors: van Rij, RP Blaak, H Visser, JA Brouwer, M Rientsma, R Broersen, S Husman, AMD Schuitemaker, H
Citation: Rp. Van Rij et al., Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1 (vol 106, pg 1039, 2000), J CLIN INV, 106(12), 2000, pp. 1569-1569

Authors: Meyer, L Magierowska, M Hubert, JB Theodorou, I van Rij, R Prins, M Husman, AMD Coutinho, R Schuitemaker, H
Citation: L. Meyer et al., CC-chemokine receptor variants, SDF-1 polymorphism, and disease progression in 720 HIV-infected patients, AIDS, 13(5), 1999, pp. 624-626

Authors: Prins, JM Jurriaans, S van Praag, RME Blaak, H van Rij, R Schellekens, PTA ten Berge, IJM Yong, SL Fox, CH Roos, MTL de Wolf, F Goudsmit, J Schuitemaker, H Lange, JMA
Citation: Jm. Prins et al., Immune-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy, AIDS, 13(17), 1999, pp. 2405-2410

Authors: Abebe, A Demissie, D Goudsmit, J Brouwer, M Kuiken, CL Pollakis, G Schuitemaker, H Fontanet, AL de Wit, TFR
Citation: A. Abebe et al., HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS, AIDS, 13(11), 1999, pp. 1305-1311

Authors: Kootstra, NA Schuitemaker, H
Citation: Na. Kootstra et H. Schuitemaker, Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages, VIROLOGY, 253(2), 1999, pp. 170-180

Authors: Berkowitz, RD van't Wout, AB Kootstra, NA Moreno, ME Linquist-Stepps, VD Bare, C Stoddart, CA Schuitemaker, H McCune, JM
Citation: Rd. Berkowitz et al., R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus, J VIROLOGY, 73(9), 1999, pp. 7817-7822
Risultati: 1-25 | 26-33